Your browser doesn't support javascript.
loading
The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey.
Al-Ezzi, Esmail M; Zahralliyali, Amer; Hansen, Aaron R; Hamilton, Robert J; Crump, Michael; Kuruvilla, John; Wood, Lori; Nappi, Lucia; Kollmannsberger, Christian K; North, Scott A; Winquist, Eric; Soulières, Denis; Hotte, Sebastien J; Jiang, Di Maria.
Afiliação
  • Al-Ezzi EM; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5S 1A1, Canada.
  • Zahralliyali A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5S 1A1, Canada.
  • Hansen AR; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5S 1A1, Canada.
  • Hamilton RJ; Division of Cancer Services, Princess Alexandra Hospital, Metro South Health, Brisbane, QLD 4113, Australia.
  • Crump M; Division of Urology, Department of Surgery, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5S 1A1, Canada.
  • Kuruvilla J; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5S 1A1, Canada.
  • Wood L; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5S 1A1, Canada.
  • Nappi L; Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS B3H 4R2, Canada.
  • Kollmannsberger CK; Department of Medicine, British Columbia Cancer Agency, University of British Columbia, Vancouver, BC V6T 1Z1, Canada.
  • North SA; Department of Medicine, British Columbia Cancer Agency, University of British Columbia, Vancouver, BC V6T 1Z1, Canada.
  • Winquist E; Division of Medical Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB T6G 2R3, Canada.
  • Soulières D; Department of Oncology, London Health Sciences Centre, Western University, London, ON N6A 3K7, Canada.
  • Hotte SJ; Département Hématologie-Oncologie, Centre Hospitalier de l'Université de Montréal, Montréal, QC H2X 0C1, Canada.
  • Jiang DM; Juravinski Cancer Centre, McMaster University, Hamilton, ON L8S 4L8, Canada.
Curr Oncol ; 30(7): 6166-6176, 2023 06 27.
Article em En | MEDLINE | ID: mdl-37504318
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Embrionárias de Células Germinativas Tipo de estudo: Guideline / Prognostic_studies Limite: Humans / Male País/Região como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Embrionárias de Células Germinativas Tipo de estudo: Guideline / Prognostic_studies Limite: Humans / Male País/Região como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article